Federal officials will use H1N1 funding to speed the process of discovering and developing drugs and vaccines in case of emergency.
Los Angeles Times
By Andrew Zajac, Tribune Washington Bureau
August 20, 2010
Reporting from Washington —
Acknowledging that the development of medical countermeasures against bioterrorism threats and pandemic flu is lagging, federal authorities Thursday announced a $1.9-billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies.